The ongoing development of new vaccines Each year throughout the world eight million deaths and hundreds of millions of cases of infectious diseases could be prevented by vaccination. Moreover, the resurgence of diseases such as tuberculosis and the increased number of antibiotic-resistant bacteria require the development of new preventive responses as rapidly as possible.
Airbone pathogens are very common and increasingly dangerous.
In the face of such planetary scourges, prevention is truly indispensable. As for airborne bacteria , we are giving priority to optimising existing vaccines against flu, tuberculosis, meningitis ACWY and respiratory pneumococcal infections. Other major research programs are focusing on malaria and dengue, the causes of hemorrhagic fevers which are widespread in Southeast Asia. For malaria , our research focuses on a multi-component vaccine in which DNA will be the main ingredient. Dengue is an haemorrhagic fever transmitted by mosquitoes increasingly widespread in Asia, South America and Oceania.